Ablexis & AlivaMab Discovery Services

[Not Yet Scheduled]
Ablexis, LLC and AlivaMab Discovery Services, LLC provide quality, speed and value, delivering unparalleled capabilities in the discovery of human therapeutic antibodies in industry leading timelines.
Ablexis created and licenses the AlivaMab Mouse, a best-in-class antibody discovery platform optimized for antibody drug discovery and development.
Ablexis has established license agreements with eight of the top 15 global pharmaceutical companies, and other public and private biotechnology companies. Ablexis offers multiple structures and flexibility in its licensing terms to accommodate companies small and large.
AlivaMab Discovery Services (ADS) provides comprehensive solutions for therapeutic antibody discovery. Built on decades of experience in antibody drug discovery, the ADS team has developed innovative processes that rapidly deliver therapeutic quality antibodies against a variety of targets, including GPCRs. Each project plan is customized based on the goals of the client.
Company Type:
Privately Funded Company
Company HQ State:
California
Company HQ Country:
United States
Year Founded:
2018
Main Therapeutic Focus:
Lead Product in Development:
Not applicable
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
photo
Chief Executive Officer
Ablexis & AlivaMab Discovery Services